Equities

SinoMab BioScience Ltd

SinoMab BioScience Ltd

Actions
  • Price (HKD)1.23
  • Today's Change0.01 / 0.82%
  • Shares traded1.06m
  • 1 Year change+4.24%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in CNYView more

In 2023, cash reserves at SinoMab BioScience Ltd fell by 139.22m. Cash Flow from Financing totalled 82.27m or 6,026.89% of revenues. In addition the company used 133.85m for operations while cash used for investing totalled 96.92m.
Cash flow per share--
Price/Cash flow per share--
Book value per share0.2798
Tangible book value per share0.2786
More ▼

Balance sheet in CNYView more

SinoMab BioScience Ltd has a Debt to Total Capital ratio of 63.39%, a lower figure than the previous year's 80.37%.
Current ratio1.31
Quick ratio--
Total debt/total equity1.73
Total debt/total capital0.6339
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.